Cell-to-cell phenotypic heterogeneity in pneumococcal pathogenesis

References

• 1. Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb. Perspect. Med. 3(7), a010215 (2013).
  MedlineGoogle Scholar
• 2. Van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374(9700), 1543–1556 (2009).
  MedlineGoogle Scholar
• 3. Keller LE, Robinson DA, McDaniel LS. Nonencapsulated Streptococcus pneumoniae: emergence and pathogenesis. MBio 7(2), e01792 (2016).
  Medline CASGoogle Scholar
• 4. Weinberger DM, Harboe ZB, Shapiro ED. Developing better pneumococcal vaccines for adults. JAMA Intern. Med. 177(3), 303–304 (2017).
  MedlineGoogle Scholar
• 5. Kim L, McGee L, Tomczyk S, Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective. Clin. Microbiol. Rev. 29(3), 525–552 (2016).
  Medline CASGoogle Scholar
• 6. Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat. Rev. Microbiol. 16(6), 355–367 (2018).
  Medline CASGoogle Scholar
• 7. Chacon-Cruz E, Martinez-Longoria CA, Llausas-Magana E et al. Neisseria meningitidis and Streptococcus pneumoniae as leading causes of pediatric bacterial meningitis in nine Mexican hospitals following 3 years of active surveillance. Ther. Adv. Vaccines 4(1–2), 15–19 (2016).
  MedlineGoogle Scholar
• 8. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood–brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Invest. 102(2), 347–360 (1998).
  Medline CASGoogle Scholar
• 9. Iovino F, Seinen J, Henriques-Normark B, van Dijl JM. How does Streptococcus pneumoniae invade the brain? Trends Microbiol. 24(4), 307–315 (2016).
  Medline CASGoogle Scholar
• 10. Surve MV, Bhutda S, Datey A et al. Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood–brain barrier trafficking. PLoS Pathog. 14(7), e1007168 (2018).
  MedlineGoogle Scholar
• 11. Paz I, Sachse M, Dupont N, Mounier J et al. Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol. 12(4), 530–544 (2010).
  Medline CASGoogle Scholar
• 12. Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482(7385), 414–418 (2012).
  Medline CASGoogle Scholar
• 13. Perrin AJ, Jiang X, Birmingham CL, So NS, Brumell JH. Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr. Biol. 14(9), 806–811 (2004).
  Medline CASGoogle Scholar
• 14. Marriott HM, Mitchell TJ, Dockrell DH. Pneumolysin: a double-edged sword during the host–pathogen interaction. Curr. Mol. Med. 8(6), 497–509 (2008).
  Medline CASGoogle Scholar
• 15. Shak JR, Ludewick HP, Howery KE et al. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. mBio 4(5), e00655–e00613 (2013).
  MedlineGoogle Scholar
• 16. Zafar MA, Wang Y, Hamaguchi S, Weiser JN. Host-to-host transmission of Streptococcus pneumoniae is driven by its inflammatory toxin, pneumolysin. Cell Host Microbe 21(1),73–83 (2017).
  Medline CASGoogle Scholar
• 17. Hirst RA, Kadioglu A, O'Callaghan C, Andrew PW. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin. Exp. Immunol. 138(2), 195–201 (2004).
  Medline CASGoogle Scholar
• 18. Harvey RM, Ogunniyi AD, Chen AY, Paton JC. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect. Immun. 79(10), 4122–4130 (2011).
  Medline CASGoogle Scholar
• 19. Berry AM, Yother J, Briles DE, Hansman D, Paton JC. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57(7), 2037–2042 (1989).
  Medline CASGoogle Scholar
• 20. Kadioglu A, Kadioglu A, Taylor S et al. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect. Immun. 70(6), 2886–2890 (2002).
  Medline CASGoogle Scholar
• 21. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190(9), 1661–1669 (2004).
  Medline CASGoogle Scholar
• 22. Shenoy AT, Brissac T, Gilley RP et al. Streptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killing. PLoS Pathog. 13(8), e1006582 (2017).
  MedlineGoogle Scholar
• 23. Avraham R, Haseley N, Brown D et al. Pathogen cell-to-cell variability drives heterogeneity in host immune responses. Cell 162(6), 1309–1321 (2015).
  Medline CASGoogle Scholar